Trial Profile
The Combination of Simeprevir and Sofosbuvir for the Treatment of HCV Infection in Patients Post Liver Transplant With Significant Fibrosis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Oct 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 12 Oct 2015 New trial record